Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Lai

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
Scientific Reports|July 19, 2020
Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective studyJingwen Yao, Akifumi Hagiwara, Catalina Raymond, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patientsRobert M Prins, Xiaoyan Wang, Horacio Soto, et al.
Neuro-Oncology|February 28, 2013
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance imagesKourosh M Naeini, Whitney B Pope, Timothy F Cloughesy, et al.
Clinical Nuclear Medicine|October 8, 2020
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI StudyHiroyuki Tatekawa, Jingwen Yao, Talia C Oughourlian, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 11, 2021
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PETHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Neuroimage|October 18, 2011
Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomasBenjamin M Ellingson, Timothy F Cloughesy, Whitney B Pope, et al.
Annals of Nuclear Medicine|June 14, 2021
Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burdenHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Journal of Neuro-Oncology|January 15, 2024
dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant gliomaSerendipity Zapanta Rinonos, Tie Li, Sean Thomas Pianka, et al.
Journal of Neuro-Oncology|September 28, 2010
Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 casesOrestes E Solis, Rupal I Mehta, Albert Lai, et al.
Radiology|September 18, 2008
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysisWhitney B Pope, Jenny H Chen, Jun Dong, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
Scientific Reports|July 19, 2020
Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective studyJingwen Yao, Akifumi Hagiwara, Catalina Raymond, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patientsRobert M Prins, Xiaoyan Wang, Horacio Soto, et al.
Neuro-Oncology|February 28, 2013
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance imagesKourosh M Naeini, Whitney B Pope, Timothy F Cloughesy, et al.
Clinical Nuclear Medicine|October 8, 2020
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI StudyHiroyuki Tatekawa, Jingwen Yao, Talia C Oughourlian, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 11, 2021
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PETHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Neuroimage|October 18, 2011
Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomasBenjamin M Ellingson, Timothy F Cloughesy, Whitney B Pope, et al.
Annals of Nuclear Medicine|June 14, 2021
Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burdenHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Journal of Neuro-Oncology|January 15, 2024
dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant gliomaSerendipity Zapanta Rinonos, Tie Li, Sean Thomas Pianka, et al.
Journal of Neuro-Oncology|September 28, 2010
Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 casesOrestes E Solis, Rupal I Mehta, Albert Lai, et al.
Radiology|September 18, 2008
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysisWhitney B Pope, Jenny H Chen, Jun Dong, et al.
Pageof 21